2021
DOI: 10.3389/fbioe.2021.671381
|View full text |Cite
|
Sign up to set email alerts
|

A Pathway From Porous Particle Technology Toward Tailoring Aerogels for Pulmonary Drug Administration

Abstract: Graphical AbstractAerogel powders are advantageous porous particles in dry powder inhalers for the pulmonary drug delivery in local and systemic treatments.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
16
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 27 publications
(16 citation statements)
references
References 88 publications
0
16
0
Order By: Relevance
“…Also, the figure revealed the presence of pores within the aggregates (Figure 8d–f) which is favorable for respiratory delivery of powders. Duong and coworkers reported the importance of porous materials for DPI formulations due to better aerodynamic performance, and provision of Large surface area 32 . ImageJ analysis of 50 aggrates revealed an average particles size of 3.07 ± 1.02 μm.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Also, the figure revealed the presence of pores within the aggregates (Figure 8d–f) which is favorable for respiratory delivery of powders. Duong and coworkers reported the importance of porous materials for DPI formulations due to better aerodynamic performance, and provision of Large surface area 32 . ImageJ analysis of 50 aggrates revealed an average particles size of 3.07 ± 1.02 μm.…”
Section: Resultsmentioning
confidence: 99%
“…Duong and coworkers reported the importance of porous materials for DPI formulations due to better aerodynamic performance, and provision of Large surface area. 32 ImageJ analysis of 50 aggrates revealed an average particles size of 3.07 ± 1.02 μm. Such results supports the aerodynamic performance analysis.…”
Section: Sem Analysismentioning
confidence: 99%
“…The present COVID-19 epidemic has sparked a resurgence of interest in pulmonary medicine drug carriers and their use in the treatment of respiratory illnesses. For example, according to Duong et al, for the existing COVID-19 condition, aerogel technologies have great potential for resolving pulmonary drug-delivery problems as in Figure 9 [ 195 ].…”
Section: Coronavirus Disease (Covid-19)mentioning
confidence: 99%
“…During drying, the water enters the organic phase and creates a porous matrix. Recently, SD INBRIJA TM (levodopa) inhalable large porous particles were approved by the EMA and FDA for commercialization as a replacement for dopamine as a fast reaction doubled with rapid growth plasma levodopa concentration for treating Parkinson disease [ 96 , 100 ].…”
Section: Approaches For Particle Engineeringmentioning
confidence: 99%